This compound is a critical pharmaceutical intermediate for the synthesis of kinase inhibitors, anti-inflammatory agents, and oncology drugs. Its unique 5-hydroxyindazole-3-carboxylic acid scaffold enables it to serve as a key building block in constructing complex heterocyclic APIs. It undergoes nucleophilic substitution, decarboxylation, and coupling reactions to form indazole-based derivatives with high biological activity. In medicinal chemistry, it is widely used in the development of JAK inhibitors, CDK inhibitors, and PARP inhibitors. The hydroxyl and carboxyl groups on the indazole ring allow facile structural modification to optimize drug potency and pharmacokinetics. High purity and good solubility in polar solvents make it suitable for both laboratory-scale synthesis and industrial production of pharmaceutical intermediates, playing an essential role in the fine chemical and pharmaceutical supply chains.

This substance is classified as a GHS warning substance (GHS07, H302: Harmful if swallowed; H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation). Inhalation of dust may irritate the respiratory tract, causing cough or shortness of breath. Skin contact can lead to redness, itching, or mild inflammation. Eye contact may result in severe irritation, tearing, or corneal discomfort. Ingestion may cause nausea, vomiting, or abdominal discomfort. Operations should be performed in a well-ventilated fume hood with dust masks, chemical-resistant gloves, and safety goggles. Avoid contact with strong acids, bases, and oxidants. Store separately from food and feed. In case of leakage, collect solids to prevent dust dispersion. Rinse skin with plenty of soapy water for 15 minutes. Flush eyes with clean water for at least 15 minutes and seek medical attention if irritation persists. If swallowed, drink plenty of water and do not induce vomiting; seek medical help promptly. Dispose of waste in accordance with local hazardous waste regulations.